"Michelle Miller, Biotron’s Managing Director, said: “We are delighted to be partnering with C14. Martina and her team have a long track record in assisting companies such as Biotron to achieve commercialisation of clinical and preclinical assets as well as platform technologies. Their involvement allows us to leverage internal expertise in a cost-effective, efficient manner. With data from the recent clinical trials in hand, together with supporting preclinical and scientific data that demonstrate the potential utility of Biotron’s unique approach to treating serious viral infections, the Company is now focused on achieving licencing or partnerships with its antiviral portfolio.”"
These* (clinical and preclinical assets as well as platform technologies) are asset to Michelle and her team because they are on job and receiving salaries, but these* are not asset to the SHs until a deal is done and SP is appreciated and SP go beyond the SP at IPO. !diot Michelle is consuming SHs' and tax payers' fund leaving her tasks on C14. SP is now all time low! They could make the CR happen during the Vibe with SP being above $0.11/s. $tupid and !diot michelle Miller = biotron and c14=BS.
BIT Price at posting:
1.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)